510(k) K932369— UROPAPER EIKEN 7

Substantially Equivalent

Tanabe U.S.A., Inc.

Clearance details

Applicant: Tanabe U.S.A., Inc.
Product code: Code JIL
Advisory panel: Clinical Chemistry
Date received: 1993-04-19
Decision date: 1993-11-16
Decision: Substantially Equivalent
Clearance type: Traditional
Location: San Diego, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.